Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. - Gottlieb, A; Menter, A; Mendelsohn, A (Lancet, 2009)
9664